Macrocyclization of Broad-Spectrum Kinase Inhibitor Bosutinib Leads to Potent and Selective Quinoline-Based HIPK4 Inhibitor AZ137 — Stanford doi.org· paper · ▲ 0 points · Aug 18, 2026
0 comments
No comments yet.